Literature DB >> 25827492

Contrast blush in pediatric blunt splenic trauma does not warrant the routine use of angiography and embolization.

Samiksha Bansal1, Frederick M Karrer2, Kristine Hansen2, David A Partrick3.   

Abstract

BACKGROUND: Splenic artery embolization (SAE) in the presence of contrast blush (CB) has been recommended to reduce the failure rate of nonoperative management. We hypothesized that the presence of CB on computed tomography has minimal impact on patient outcomes.
METHODS: A retrospective review was conducted of all children (<18 years) with blunt splenic trauma over a 10-year period at a level 1 pediatric trauma center. Data are presented as mean ± standard error of mean.
RESULTS: Seven hundred forty children sustained blunt abdominal trauma, of which 549 had an identified solid organ injury. Blunt splenic injury was diagnosed in 270 of the 740 patients. All patients were managed nonoperatively without SAE. CB was seen on computed tomography in 47 patients (17.4%). There were no significant differences in the need for blood transfusion (12.5% vs 11.1%) or length of stay (3.1 vs 3.3 days) or need for splenectomy when compared in children with or without CB.
CONCLUSION: Pediatric trauma patients with blunt splenic injuries can be safely managed without SAE and physiologic response and hemodynamic stability should be the primary determinants of appropriate management.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angiographic embolization; Contrast blush; Pediatric; Splenic trauma

Mesh:

Year:  2015        PMID: 25827492     DOI: 10.1016/j.amjsurg.2014.09.028

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  5 in total

Review 1.  Update: Splenic Artery Embolization in Blunt Abdominal Trauma.

Authors:  Mangaladevi S Patil; Sean Z Goodin; Laura K Findeiss
Journal:  Semin Intervent Radiol       Date:  2020-03-04       Impact factor: 1.513

Review 2.  Pediatric trauma and the role of the interventional radiologist.

Authors:  Aparna Annam; Shellie Josephs; Thor Johnson; Ann M Kulungowski; Richard B Towbin; Anne Marie Cahill
Journal:  Emerg Radiol       Date:  2022-06-09

Review 3.  Splenic trauma: WSES classification and guidelines for adult and pediatric patients.

Authors:  Federico Coccolini; Giulia Montori; Fausto Catena; Yoram Kluger; Walter Biffl; Ernest E Moore; Viktor Reva; Camilla Bing; Miklosh Bala; Paola Fugazzola; Hany Bahouth; Ingo Marzi; George Velmahos; Rao Ivatury; Kjetil Soreide; Tal Horer; Richard Ten Broek; Bruno M Pereira; Gustavo P Fraga; Kenji Inaba; Joseph Kashuk; Neil Parry; Peter T Masiakos; Konstantinos S Mylonas; Andrew Kirkpatrick; Fikri Abu-Zidan; Carlos Augusto Gomes; Simone Vasilij Benatti; Noel Naidoo; Francesco Salvetti; Stefano Maccatrozzo; Vanni Agnoletti; Emiliano Gamberini; Leonardo Solaini; Antonio Costanzo; Andrea Celotti; Matteo Tomasoni; Vladimir Khokha; Catherine Arvieux; Lena Napolitano; Lauri Handolin; Michele Pisano; Stefano Magnone; David A Spain; Marc de Moya; Kimberly A Davis; Nicola De Angelis; Ari Leppaniemi; Paula Ferrada; Rifat Latifi; David Costa Navarro; Yashuiro Otomo; Raul Coimbra; Ronald V Maier; Frederick Moore; Sandro Rizoli; Boris Sakakushev; Joseph M Galante; Osvaldo Chiara; Stefania Cimbanassi; Alain Chichom Mefire; Dieter Weber; Marco Ceresoli; Andrew B Peitzman; Liban Wehlie; Massimo Sartelli; Salomone Di Saverio; Luca Ansaloni
Journal:  World J Emerg Surg       Date:  2017-08-18       Impact factor: 5.469

4.  Splenic injury severity, not admission hemodynamics, predicts need for surgery in pediatric blunt splenic trauma.

Authors:  Michel Teuben; Roy Spijkerman; Henrik Teuber; Roman Pfeifer; Hans-Christoph Pape; William Kramer; Luke Leenen
Journal:  Patient Saf Surg       Date:  2020-01-03

5.  Utility of Angioembolization in Patients with Abdominal and Pelvic Traumatic Bleeding: Descriptive Observational Analysis from a Level 1 Trauma Center.

Authors:  Hassan Al-Thani; Husham Abdelrahman; Ali Barah; Mohammad Asim; Ayman El-Menyar
Journal:  Ther Clin Risk Manag       Date:  2021-04-19       Impact factor: 2.423

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.